Intercontinental Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$421K Buy
5,458
+126
+2% +$10K 0.1% 209
2023
Q1
$442K Sell
5,332
-31
-0.6% -$2.57K 0.11% 209
2022
Q4
$460K Sell
5,363
-4,874
-48% -$386K 0.14% 178
2022
Q3
$632K Buy
10,237
+481
+5% +$30.3K 0.2% 116
2022
Q2
$603K Buy
9,756
+482
+5% +$29.8K 0.16% 137
2022
Q1
$551K Buy
9,274
+70
+0.8% +$4.47K 0.13% 170
2021
Q4
$668K Buy
9,204
+955
+12% +$65.8K 0.14% 148
2021
Q3
$576K Sell
8,249
-480
-5% -$33.7K 0.13% 148
2021
Q2
$601K Buy
8,729
+3,834
+78% +$256K 0.12% 157
2021
Q1
$316K Buy
4,895
+16
+0.3% +$1.03K 0.07% 207
2020
Q4
$284K Sell
4,879
-134
-3% -$8.09K 0.07% 205
2020
Q3
$317K Buy
5,013
+705
+16% +$48.9K 0.09% 158
2020
Q2
$331K Buy
4,308
+492
+13% +$37.7K 0.11% 137
2020
Q1
$285K Buy
3,816
+854
+29% +$59K 0.15% 117
2019
Q4
$195K Buy
2,962
+1,133
+62% +$73.8K 0.16% 110
2019
Q3
$116K Buy
1,829
+103
+6% +$6.73K 0.07% 162
2019
Q2
$117K Buy
1,726
+3
+0.2% +$197 0.06% 154
2019
Q1
$112K Buy
1,723
+438
+34% +$29.1K 0.06% 163
2018
Q4
$80K Buy
+1,285
New +$89.8K 0.04% 180
2018
Q1
Sell
-4,540
Closed -$325K 143
2017
Q4
$325K Sell
4,540
-165
-4% -$12.5K 0.18% 81
2017
Q3
$381K Buy
4,705
+3
+0.1% +$229 0.23% 73
2017
Q2
$333K Sell
4,702
-375
-7% -$25K 0.21% 78
2017
Q1
$345K Buy
5,077
+1,734
+52% +$122K 0.21% 89
2016
Q4
$239K Buy
+3,343
New +$248K 0.15% 127

Other funds holding GILD

Intercontinental Wealth Advisors's GILD Position: Q2 2023 in Review

Intercontinental Wealth Advisors increased its Gilead Sciences (GILD) stake by 2.4% in Q2 2023, buying an estimated $10K and bringing the position to 5,458 shares worth $421K. The position accounts for 0.1% of the portfolio, ranked #209.

Intercontinental Wealth Advisors first reported a position in GILD in Q4 2016 and has held it in 24 quarters since. The position peaked at $668K in Q4 2021. 1,702 funds tracked by Wall St. Rank hold GILD as of Q2 2023.

  • Intercontinental Wealth Advisors held 5,458 shares of Gilead Sciences worth $421K as of Q2 2023.
  • Intercontinental Wealth Advisors bought 126 Gilead Sciences shares in Q2 2023, an estimated $10K.
  • Gilead Sciences made up 0.1% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #209 holding.
  • Intercontinental Wealth Advisors first reported a position in Gilead Sciences in Q4 2016 and has held it in 24 quarters since.
  • Intercontinental Wealth Advisors's Gilead Sciences position peaked at $668K in Q4 2021.
  • 1,702 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2023.

Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.